Treatment of childhood acute lymphoblastic leukaemia with the BFM regimen.

G. C. Kudva*, M. Chandy, P. Raghupathy, D. Dennison, A. Srivastava, V. Bhushan, R. Singh

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)


Thirty-eight children with acute lymphoblastic leukaemia were treated with the BFM regimen. Thirty-six (94.7%) achieved complete remission (CR). Twenty 58.8%) of 34 evaluable patients are in continuous complete remission (CCR) at a median follow-up of 33 (range 19-81) months. Long-term disease-free survival was better in the 2-9 years age group (83%) when compared to the 10-14 years group (43%) (P < .05).

Original languageEnglish
Pages (from-to)78-85
Number of pages8
JournalIndian Journal of Cancer
Issue number2
Publication statusPublished - Jun 1994

ASJC Scopus subject areas

  • Oncology


Dive into the research topics of 'Treatment of childhood acute lymphoblastic leukaemia with the BFM regimen.'. Together they form a unique fingerprint.

Cite this